{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:40:01Z","timestamp":1776753601672,"version":"3.51.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:00:00Z","timestamp":1535155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12883-018-1129-x","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T08:20:25Z","timestamp":1535185225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Characterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregivers"],"prefix":"10.1186","volume":"18","author":[{"given":"Daniel O.","family":"Claassen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Arthur","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,25]]},"reference":[{"key":"1129_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69\u201372.","journal-title":"Clin Auton Res"},{"key":"1129_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.parkreldis.2011.05.020","volume":"17","author":"AD Ha","year":"2011","unstructured":"Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011;17:625\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"1129_CR3","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1007\/s00415-012-6736-7","volume":"260","author":"M Metzler","year":"2013","unstructured":"Metzler M, Duerr S, Granata R, Krismer F, Robertson D, Wenning GK. Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management. J Neurol. 2013;260:2212\u20139.","journal-title":"J Neurol"},{"key":"1129_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/jnnp.63.5.584","volume":"63","author":"JM Senard","year":"1997","unstructured":"Senard JM, Rai S, Lapeyre-Mestre M, Brefel C, Rascol O, Rascol A, et al. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;63:584\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1129_CR5","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","volume":"264","author":"CH Gibbons","year":"2017","unstructured":"Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264:1567\u201382.","journal-title":"J Neurol"},{"key":"1129_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/CIRCULATIONAHA.108.805887","volume":"119","author":"DS Goldstein","year":"2009","unstructured":"Goldstein DS, Sharabi Y. Neurogenic orthostatic hypotension: a pathophysiological approach. Circulation. 2009;119:139\u201346.","journal-title":"Circulation"},{"key":"1129_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/jch.12062","volume":"15","author":"C Shibao","year":"2013","unstructured":"Shibao C, Lipsitz LA, Biaggioni I. ASH position paper: evaluation and treatment of orthostatic hypotension. J Clin Hypertens (Greenwich). 2013;15:147\u201353.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1129_CR8","first-page":"439","volume":"46","author":"C McDonald","year":"2017","unstructured":"McDonald C, Pearce M, Kerr SR. Newton J. A prospective study of the association between orthostatic hypotension and falls: definition matters. Age Ageing. 2017;46:439\u201345.","journal-title":"Age Ageing"},{"key":"1129_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0002-9343(99)00425-8","volume":"108","author":"WL Ooi","year":"2000","unstructured":"Ooi WL, Hossain M, Lipsitz LA. The association between orthostatic hypotension and recurrent falls in nursing home residents. Am J Med. 2000;108:106\u201311.","journal-title":"Am J Med"},{"key":"1129_CR10","first-page":"475854","volume":"2014","author":"SM Fereshtehnejad","year":"2014","unstructured":"Fereshtehnejad SM, Lokk J. Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsons Dis. 2014;2014:475854.","journal-title":"Parkinsons Dis"},{"key":"1129_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s10286-005-0253-z","volume":"15","author":"C Magerkurth","year":"2005","unstructured":"Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res. 2005;15:76\u201382.","journal-title":"Clin Auton Res"},{"key":"1129_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11910-015-0599-0","volume":"15","author":"KE McDonell","year":"2015","unstructured":"McDonell KE, Shibao CA, Claassen DO. Clinical relevance of orthostatic hypotension in neurodegenerative disease. Curr Neurol Neurosci Rep. 2015;15:78.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1129_CR13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMcp074189","volume":"358","author":"R Freeman","year":"2008","unstructured":"Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med. 2008;358:615\u201324.","journal-title":"N Engl J Med"},{"key":"1129_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/15524256.2017.1282917","volume":"13","author":"J Cagle","year":"2017","unstructured":"Cagle J, Bunting M. Patient reluctance to discuss pain: understanding stoicism, stigma, and other contributing factors. J Soc Work End Life Palliat Care. 2017;13:27\u201343.","journal-title":"J Soc Work End Life Palliat Care"},{"key":"1129_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4088\/JCP.11m07078","volume":"73","author":"N Sawada","year":"2012","unstructured":"Sawada N, Uchida H, Watanabe K, Kikuchi T, Suzuki T, Kashima H, et al. How successful are physicians in eliciting the truth from their patients? A large-scale internet survey from patients\u2019 perspectives. J Clin Psychiatry. 2012;73:311\u20137.","journal-title":"J Clin Psychiatry"},{"key":"1129_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1017\/S0144686X11001243","volume":"33","author":"LH Clarke","year":"2013","unstructured":"Clarke LH, Bennett E. \u201cyou learn to live with all the you\u201d: gender and the experience of multiple chronic conditions in later life. Ageing Soc. 2013;33:342\u201360.","journal-title":"Ageing Soc"},{"key":"1129_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/VHRM.S53983","volume":"10","author":"SH Isaacson","year":"2014","unstructured":"Isaacson SH, Skettini J. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa. Vasc Health Risk Manag. 2014;10:169\u201376.","journal-title":"Vasc Health Risk Manag"},{"key":"1129_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2016.09.013","volume":"33","author":"A Merola","year":"2016","unstructured":"Merola A, Romagnolo A, Rosso M, Lopez-Castellanos JR, Wissel BD, Larkin S, et al. Orthostatic hypotension in Parkinson's disease: does it matter if asymptomatic? Parkinsonism Relat Disord. 2016;33:65\u201371.","journal-title":"Parkinsonism Relat Disord"},{"key":"1129_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/mds.27344","volume":"33","author":"JA Palma","year":"2018","unstructured":"Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord. 2018;33:372\u201390.","journal-title":"Mov Disord"},{"key":"1129_CR20","first-page":"iii31","volume":"74","author":"C Mathias","year":"2003","unstructured":"Mathias C. Autonomic diseases: clinical features and laboratory evaluation. J Neurol Neurosurg Psychiatry. 2003;74:iii31\u201341.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1129_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/pgmj.70.827.638","volume":"70","author":"GM Craig","year":"1994","unstructured":"Craig GM. Clinical presentation of orthostatic hypotension in the elderly. Postgrad Med J. 1994;70:638\u201342.","journal-title":"Postgrad Med J"},{"key":"1129_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10286-013-0219-5","volume":"24","author":"BH Shaw","year":"2014","unstructured":"Shaw BH, Claydon VE. The relationship between orthostatic hypotension and falling in older adults. Clin Auton Res. 2014;24:3\u201313.","journal-title":"Clin Auton Res"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1129-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-018-1129-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1129-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T23:03:55Z","timestamp":1566687835000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-018-1129-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,25]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1186\/s12883-018-1129-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,25]]},"assertion":[{"value":"6 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with ethical standards (e.g., 1964 Helsinki Declaration and later amendments or the comparable). Respondents were selected from individuals who agreed to participate in Harris Poll online surveys or were members of certain advocacy organizations who actively decided to participate in the survey. For research in which participants are intended to remain anonymous, Harris Poll uses tools and methods to ensure that there is no reasonable possibility of identifying an individual participant in the reports created (e.g., individual responses collected are combined to produce \u201caggregated\u201d reports). As an anonymous survey, the study was exempt from ethics approval based on Code of Federal Regulations Title 45, Part 46, Subpart A, Section 46.101b, Category 2 criteria.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DOC receives grant support from the National Institutes of Health and the Michael J. Fox Foundation for Parkinson\u2019s Research; is a site investigator for clinical trials sponsored by Vaccinex, AbbVie, CHDI, and Auspex\/Teva Neuroscience; and has received personal remuneration from Lundbeck, Teva Neuroscience, Acadia, and AbbVie for consulting, advisory board participation, and speaking honoraria. CHA has received research funding from the National Institutes of Health and the Michael J. Fox Foundation for Parkinson\u2019s Research and consulting fees from Acadia, Acorda, Adamas, Cynapsus, Jazz, Lundbeck, Minerva, Neurocrine, and Sunovion. LAH is an employee of Lundbeck Medical Affairs. CG has served on advisory boards for Lundbeck and Pfizer and on data safety monitoring boards for Janssen and Astellas, and has received grants from Grifols and Celgene.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"125"}}